Drivers and Risk Factors of Unplanned 30‐Day Readmission Following Spinal Cord Stimulator Implantation
Elsamadicy AA, Sergesketter A, Ren X, Hussaini S, Laarakker A, Rahimpour S, Ejikeme T, Yang S, Pagadala P, Parente B, Xie J, Lad SP. Drivers and Risk Factors of Unplanned 30‐Day Readmission Following Spinal Cord Stimulator Implantation. Neuromodulation Technology At The Neural Interface 2017, 21: 87-92. PMID: 28961362, PMCID: PMC5766416, DOI: 10.1111/ner.12689.Peer-Reviewed Original ResearchConceptsSpinal cord stimulator implantationSCS implantationUnplanned readmissionIndependent predictorsPatient demographicsReadmission ratesMechanical complicationsStimulator implantationBaseline patient demographicsNational Readmission DatabaseReadmission statusNational healthcare expendituresPrimary outcomeHospital characteristicsRisk factorsPatient outcomesReadmissionMultivariate analysisPatientsSCS deviceHealthcare expendituresComorbiditiesImplantationComplicationsObesityLong-term Cost Utility of Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome.
Farber SH, Han JL, Elsamadicy AA, Hussaini Q, Yang S, Pagadala P, Parente B, Xie J, Lad SP. Long-term Cost Utility of Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome. Pain Physician 2017, 20: e797-e805. PMID: 28934786, PMCID: PMC8358894, DOI: 10.36076/ppj.20.5.e797.Peer-Reviewed Original ResearchConceptsConventional medical managementSpinal cord stimulationFBSS patientsSurgery syndromeCord stimulationSCS systemCost utilityFailed Back Surgery SyndromeBack surgery syndromePrior back surgeryGEE modelHealth care utilizationRandomized clinical trialsConventional managementLongitudinal GEE modelsTime of implantationLeg painSCS implantationBack painCare utilizationLong followMedical managementSignificant morbidityBack surgeryTreatment optionsImpact of Insurance Provider on Overall Costs in Failed Back Surgery Syndrome: A Cost Study of 122,827 Patients
Elsamadicy AA, Farber SH, Yang S, Hussaini SMQ, Murphy KR, Sergesketter A, Suryadevara CM, Pagadala P, Parente B, Xie J, Lad SP. Impact of Insurance Provider on Overall Costs in Failed Back Surgery Syndrome: A Cost Study of 122,827 Patients. Neuromodulation Technology At The Neural Interface 2017, 20: 354-360. PMID: 28322477, PMCID: PMC5482408, DOI: 10.1111/ner.12584.Peer-Reviewed Original ResearchConceptsMedian total costSCS implantationFBSS patientsSurgery syndromeMedicare cohortFailed Back Surgery SyndromeManagement of FBSSBack surgery syndromeUnnecessary health care expendituresInsurance providersSpinal cord stimulationRetrospective longitudinal studySignificant differencesUS health care systemHealth care systemHealth care expendituresMedicaid cohortBaseline characteristicsCord stimulationTruven MarketScanCost differencesSpine surgeryMedicare patientsPatientsDifferent insurance providers